HK1055996A1 - Posh nucleic acids, polypeptides and related methods - Google Patents

Posh nucleic acids, polypeptides and related methods

Info

Publication number
HK1055996A1
HK1055996A1 HK03108245A HK03108245A HK1055996A1 HK 1055996 A1 HK1055996 A1 HK 1055996A1 HK 03108245 A HK03108245 A HK 03108245A HK 03108245 A HK03108245 A HK 03108245A HK 1055996 A1 HK1055996 A1 HK 1055996A1
Authority
HK
Hong Kong
Prior art keywords
nucleic acids
related methods
polypeptides
posh nucleic
posh
Prior art date
Application number
HK03108245A
Other languages
English (en)
Inventor
Iris Alroy
Shmuel Tuvia
Tsvika Greener
Danny Ben-Avraham
Original Assignee
Proteologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteologics Inc filed Critical Proteologics Inc
Publication of HK1055996A1 publication Critical patent/HK1055996A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
    • C12Y603/02019—Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK03108245A 2001-11-09 2003-11-13 Posh nucleic acids, polypeptides and related methods HK1055996A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34584601P 2001-11-09 2001-11-09
US36453002P 2002-03-15 2002-03-15

Publications (1)

Publication Number Publication Date
HK1055996A1 true HK1055996A1 (en) 2004-01-30

Family

ID=26994569

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108245A HK1055996A1 (en) 2001-11-09 2003-11-13 Posh nucleic acids, polypeptides and related methods

Country Status (11)

Country Link
US (4) US7250250B2 (xx)
EP (1) EP1310552B1 (xx)
JP (1) JP2005519636A (xx)
AT (1) ATE364690T1 (xx)
AU (1) AU2002365160C1 (xx)
CA (1) CA2465973C (xx)
DE (1) DE60220621T2 (xx)
HK (1) HK1055996A1 (xx)
IL (2) IL161764A0 (xx)
NZ (1) NZ532908A (xx)
WO (1) WO2003095971A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004025708D1 (de) 2003-07-11 2010-04-08 Proteologics Inc Ubiquitin-ligase-hemmer und verwandte verfahren
US20060188890A1 (en) * 2003-10-31 2006-08-24 Proteologics, Inc. Ubiquitin-based protein interaction assays and related compositions
JP2008517278A (ja) * 2004-10-15 2008-05-22 シグナル ファーマシューティカルズ，エルエルシー ｐ２７のユビキチン化アッセイ及びその使用方法
CA2588752A1 (en) * 2004-12-01 2006-06-08 Proteologics, Inc. Ubiquitin ligase assays and related reagents
JP2008092911A (ja) * 2006-10-16 2008-04-24 Univ Of Tokyo タンパク質結合検出方法
EP2196794A4 (en) * 2007-08-30 2014-04-02 Mitsui Shipbuilding Eng DEVICE AND METHOD FOR DETECTING FLUORESCENCE ENERGY TRANSFER (FRET)
EP2346883B1 (en) 2008-09-23 2016-03-23 Scott G. Petersen Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
WO2015023824A2 (en) * 2013-08-14 2015-02-19 The Curators Of The University Of Missouri Cell permeable inhibitors of the scaffold protein plenty of sh3 domains (posh) or sh3rfl
US12059413B2 (en) 2016-11-02 2024-08-13 The Research Foundation For The State University Of New York Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction
CN106754883B (zh) * 2016-12-30 2019-10-29 中山大学 一种一步、无缝、非同源、多片段的基因拼接改造方法及其试剂盒
CN112764372A (zh) * 2020-12-25 2021-05-07 天津大学 基于vpx架构的多通道信号采集系统

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002524049A (ja) * 1998-08-07 2002-08-06 オニックス ファーマシューティカルズ，インコーポレイティド Ｃｈｐポリペプチド、ｐａｋ６５のリガンド
AU6158799A (en) * 1998-10-13 2000-05-01 Onyx Pharmaceuticals, Inc. Novel cell signaling polypeptides and nucleic acids
WO2000027865A1 (en) 1998-11-06 2000-05-18 The Brigham And Women's Hospital, Inc. CHARACTERIZATION OF NOVEL GENE cbl-SL
WO2001088088A2 (en) 2000-05-18 2001-11-22 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
AU7701100A (en) 1999-09-03 2001-04-10 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
CA2393002A1 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1572987A4 (en) 2000-02-03 2005-11-30 Nuvelo Inc NUCLEIC ACIDS AND POLYPEPTIDES
WO2001060860A2 (en) 2000-02-17 2001-08-23 Millennium Predictive Medicine, Inc. Genes differentially expressed in human prostate cancer and their use
AU2001238347A1 (en) 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2001070979A2 (en) 2000-03-21 2001-09-27 Millennium Pharmaceuticals, Inc. Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
WO2001071042A2 (en) 2000-03-23 2001-09-27 Pe Corporation (Ny) Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
WO2001077288A2 (en) 2000-04-06 2001-10-18 Genetics Institute, Llc. Polynucleotides encoding novel secreted proteins
EP1339872A2 (en) 2000-09-19 2003-09-03 Whitehead Institute For Biomedical Research Genetic markers for tumors
EP1334113A4 (en) 2000-10-20 2007-08-08 Expression Diagnostics Inc EVALUATION OF LEUCOCYTAIRE EXPRESSION LEVEL
EP1629082A4 (en) 2000-10-20 2009-07-22 Univ Massachusetts GENERIC CONNECTIONS AND THEIR USES OF GLUCOSE TRANSPORT
AU2002241520A1 (en) 2000-11-28 2003-03-03 University Of Cincinnati Blood assessment of injury
WO2002077235A2 (en) 2000-12-21 2002-10-03 Incyte Genomics, Inc. Intracellular signaling molecules
WO2002053719A2 (en) * 2001-01-04 2002-07-11 Incyte Genomics, Inc. Cytoskeleton-associated proteins
CA2440703A1 (en) 2001-01-24 2002-08-01 Protein Design Labs, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
US6743619B1 (en) 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
AU2002237124B2 (en) 2001-02-28 2008-03-06 Chondrogene Inc. Compositions and methods relating to osteoarthritis
CA2442705A1 (en) * 2001-03-28 2002-12-05 Incyte Genomics, Inc. Molecules for diagnostics and therapeutics
AU2002311787A1 (en) 2001-03-28 2002-10-15 Zycos Inc. Translational profiling
WO2002085285A2 (en) 2001-04-18 2002-10-31 Wyeth Methods and reagents for regulating bone and cartilage formation
WO2002095000A2 (en) 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
WO2003022987A2 (en) 2001-07-26 2003-03-20 Eos Biotechnology, Inc. Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection
US20050181355A1 (en) 2001-07-31 2005-08-18 Tsvika Greener Compositions and methods for the modulation of viral maturation
AU2002330039A1 (en) 2001-09-17 2003-04-01 Eos Biotechnology, Inc. Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
WO2003038130A2 (en) 2001-10-31 2003-05-08 Pfizer Products Inc. Therapeutics and diagnostics for disorders of erythropoiesis
US20030175253A1 (en) 2001-11-09 2003-09-18 Huda Akil Compositions and methods for diagnosing and treating mental disorders
US20040096828A1 (en) * 2002-01-04 2004-05-20 Lu Dyung Aina M Cytoskeleton-associated proteins

Also Published As

Publication number Publication date
US20060019240A1 (en) 2006-01-26
IL161764A (en) 2010-12-30
EP1310552A3 (en) 2003-10-08
CA2465973A1 (en) 2003-11-20
US20040025196A1 (en) 2004-02-05
US7268227B2 (en) 2007-09-11
US7429643B2 (en) 2008-09-30
AU2002365160C1 (en) 2009-08-13
AU2002365160B2 (en) 2008-10-30
AU2002365160A1 (en) 2003-11-11
US20060035213A1 (en) 2006-02-16
DE60220621T2 (de) 2008-03-06
ATE364690T1 (de) 2007-07-15
IL161764A0 (en) 2005-11-20
JP2005519636A (ja) 2005-07-07
WO2003095971A3 (en) 2005-04-28
WO2003095971A2 (en) 2003-11-20
DE60220621D1 (de) 2007-07-26
NZ532908A (en) 2008-04-30
CA2465973C (en) 2013-04-16
EP1310552B1 (en) 2007-06-13
US7250250B2 (en) 2007-07-31
US20080187538A1 (en) 2008-08-07
EP1310552A2 (en) 2003-05-14

Similar Documents

Publication Publication Date Title
AU1593001A (en) Recombinant gelatin in vaccines
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
EP1381621A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
PL366621A1 (en) Core-glycosylated hcv envelope proteins
AU2002343417A1 (en) Novel nucleic acids and polypeptides
HK1055996A1 (en) Posh nucleic acids, polypeptides and related methods
IL162274A (en) Nucleic acid and protein designated 193p1e1b and compositions containing the same
EP1273658A4 (en) NEW PROTEIN, THEIR DNA AND METHOD FOR THE PRODUCTION THEREOF
EP1368475A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
IL158293A0 (en) Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
WO2005001485A3 (en) Pem-3-like compositions and related methods thereof
AU2002250419A1 (en) Novel nucleic acids and polypeptides
EP1433849A4 (en) NEW POLYPEPTIDE, HIS DNA, AND USE THEREOF
IL160651A (en) Nucleic acid and corresponding protein entitled 205pib5 and pharmaceutical compositions containing the same and uses thereof
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
AU2002316348A1 (en) Chimeric capsid proteins and uses thereof
AU2002344252A1 (en) Mammalian diabetes-mediating proteins
AU2002357609A1 (en) Novel proteins and dnas thereof
CA2530618A1 (en) Novel calcium channel
WO2002102992A8 (en) Novel nucleic acids, polypeptides, methods of making, and uses thereof
EP1375663A4 (en) NEW PROTEIN, ITS DNA AND USE
SE0102223D0 (sv) Kompostbehållare "Wisky"
EP1370675A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141111